scholarly journals A Comparison of Tertiary Drug Resources’ Consistency Regarding Drug-Drug Interactions of Adjunctive Analgesics

2020 ◽  
pp. 875512252095133
Author(s):  
Andrew Lang ◽  
Michael A. Veronin ◽  
Justin P. Reinert

Background: Health care providers routinely rely on tertiary drug information resources to affirm knowledge or proactively verify the safety and efficacy of medications. Though all patient care areas are affected, the reliability of these resources is perhaps nowhere as poignant as it is in high-acuity settings, including the emergency department and the intensive care unit. As providers seek to identify adjunctive analgesics for acute pain in these areas, they must be able to rely on the integrity to whichever resource their institution has granted access. Objective: To determine the congruency of drug-drug interaction information found on 3 tertiary drug resources. Methods: A drug-drug interaction analysis was conducted on Micromedex, Lexicomp, and Medscape. Adjunctive analgesics included dexmedetomidine and ketamine, which were compared with the intravenous opioid products morphine, fentanyl, and hydromorphone. Results: Significant discrepancies were appreciated with regard to the severity of drug-drug interactions. In addition, the heterogeneity in which reaction severity and likelihood are described by each respective resource makes direct comparisons difficult. Interaction warnings for dexmedetomidine and fentanyl included a “major interaction” from Micromedex, whereas Lexicomp did not identify a risk and Medscape only recommended increased monitoring on the grounds of respiratory and central nervous system depression. Conclusions: Health care providers must remain vigilant when reviewing tertiary drug information resources. Pharmacists possess the training and skills necessary to assist interdisciplinary medical teams in providing optimal patient care through evaluating and applying the information gleaned from these resources.

Author(s):  
Kathel Dunn ◽  
Joanne Gard Marshall ◽  
Amber L. Wells ◽  
Joyce E. B. Backus

Objective: This study analyzed data from a study on the value of libraries to understand the specific role that the MEDLINE database plays in relation to other information resources that are available to health care providers and its role in positively impacting patient care.Methods: A previous study on the use of health information resources for patient care obtained 16,122 responses from health care providers in 56 hospitals about how providers make decisions affecting patient care and the role of information resources in that process. Respondents indicated resources used in answering a specific clinical question from a list of 19 possible resources, including MEDLINE. Study data were examined using descriptive statistics and regression analysis to determine the number of information resources used and how they were used in combination with one another.Results: Health care professionals used 3.5 resources, on average, to aid in patient care. The 2 most frequently used resources were journals (print and online) and the MEDLINE database. Using a higher number of information resources was significantly associated with a higher probability of making changes to patient care and avoiding adverse events. MEDLINE was the most likely to be among consulted resources compared to any other information resource other than journals.Conclusions: MEDLINE is a critical clinical care tool that health care professionals use to avoid adverse events, make changes to patient care, and answer clinical questions.


2015 ◽  
Vol 2015 ◽  
pp. 1-13 ◽  
Author(s):  
Christoph Rinner ◽  
Wilfried Grossmann ◽  
Simone Katja Sauter ◽  
Michael Wolzt ◽  
Walter Gall

Shared electronic health records (EHRs) systems can offer a complete medication overview of the prescriptions of different health care providers. We use health claims data of more than 1 million Austrians in 2006 and 2007 with 27 million prescriptions to estimate the effect of shared EHR systems on drug-drug interaction (DDI) and duplication warnings detection and prevention. The Austria Codex and the ATC/DDD information were used as a knowledge base to detect possible DDIs. DDIs are categorized as severe, moderate, and minor interactions. In comparison to the current situation where only DDIs between drugs issued by a single health care provider can be checked, the number of warnings increases significantly if all drugs of a patient are checked: severe DDI warnings would be detected for 20% more persons, and the number of severe DDI warnings and duplication warnings would increase by 17%. We show that not only do shared EHR systems help to detect more patients with warnings but DDIs are also detected more frequently. Patient safety can be increased using shared EHR systems.


Author(s):  
Brandon H. Samson ◽  
James D. Scott

The prevalence of HIV infection is increasing in the older population. Because of other comorbidities, older patients infected with HIV may be taking multiple medications, which increases the risk of drug–drug interactions. Treatment of HIV in aging patients is based on the consideration of adverse effects associated by antiretroviral therapy (ART) with regard to renal, hepatic, cardiovascular, metabolic, and bone health, as well as the potential for increased drug–drug interactions. Because ART is associated with both beneficial and deleterious effects, health care providers should weigh the negative effects against the positive effects of viral suppression. Health care providers should routinely review patients’ medication lists to search for significant drug–drug interactions and perform drug interaction checks using available resources.


2018 ◽  
Vol 71 (1) ◽  
Author(s):  
Cynthia Cheng ◽  
Fatima Mithoowani ◽  
Thomas Ungar ◽  
Monica Lee

<p><strong>ABSTRACT</strong></p><p><strong>Background: </strong>Interaction between alcohol and certain medications can lead to adverse consequences. Individuals with mental health disorders are particularly vulnerable because of their psychotropic medications, which are typically taken over extended periods and which are known to have pharmacokinetic and pharmacodynamic interactions with alcohol. It is unknown what education these patients receive from their health care providers and how such interactions are managed.</p><p><strong>Objectives: </strong>To determine whether individuals with mental health disorders are aware of alcohol–drug interactions and if so, how they use such information.</p><p><strong>Methods: </strong>A questionnaire was developed to explore the perceptions of mental health patients concerning alcohol–drug interactions. The questionnaire included questions in 3 domains: knowledge of potential alcohol–drug interactions, consumption of alcohol while taking psychotropic medications, and source of advice regarding the interactions. Attendees of an adult mental health day hospital program were invited to participate.</p><p><strong>Results: </strong>A total of 131 participants answered the questionnaire between July 2014 and February 2015; 31 of the questionnaires were incomplete and were excluded from analysis. Of the 100 participants included in the analyses, 75 reported having received counselling from a health care provider about alcohol–drug interactions, and 49 of these reported following the advice provided. The most common advice reported by participants was to avoid alcohol consumption while taking medications. Serious adverse effects, such as worsening of a psychiatric condition, admission to hospital, and increased drowsiness, were reported by 23 participants. Sixty-nine participants considered physicians to be the best source of information about these interactions.</p><p><strong>Conclusions: </strong>Most participants reported that they had received information about strategies to avoid negative consequences from alcohol–drug interactions. Nevertheless, consumption of alcohol occurred, and almost one-quarter of participants reported a serious adverse effect related to consuming alcohol. These self-reported data indicate that patients do not necessarily follow the advice of their health care providers. Future studies should explore reasons for the gap between advice and action and how to minimize it.</p><p><strong> </strong></p><p><strong>RÉSUMÉ</strong></p><p><strong>Contexte : </strong>L’interaction entre l’alcool et certains médicaments peut mener à des conséquences cliniques. Les personnes atteintes de troubles mentaux y sont particulièrement vulnérables à cause des médicaments psychotropes qu’ils prennent d’habitude sur une période prolongée et pour lesquels les interactions pharmacocinétiques et pharmacodynamiques avec l’alcool sont notoires. On ne sait pas quels conseils ces patients reçoivent de leurs fournisseurs de soins de santé et comment de telles interactions sont gérées.</p><p><strong>Objectifs :</strong>Déterminer si les personnes atteintes de troubles mentaux sont conscientes des interactions entre l’alcool et les médicaments et, si oui, dévoiler comment elles agissent à la lumière de cette information.</p><p><strong>Méthodes : </strong>On a mis au point un questionnaire pour enquêter sur les perceptions qu’ont les patients atteints de troubles mentaux des interactions alcool-médicaments. Les questions y étaient regroupées en trois catégories : conscience des interactions potentielles alcool-médicaments, consummation d’alcool en prenant des psychotropes et source des conseils sur les interactions. Les participants à un programme hospitalier de jour pour adultes atteints de troubles mentaux ont été invités à participer à l’étude.</p><p><strong>Résultats : </strong>Au total, 131 participants ont rempli le questionnaire entre juillet 2014 et février 2015; 31 des questionnaires étaient incomplets et ont été exclus de l’analyse. Parmi les 100 participants inclus dans les analyses, 75 ont indiqué avoir reçu des conseils d’un fournisseur de soins de santé sur les interactions alcool-médicaments et 49 d’entre eux ont affirmé avoir suivi les conseils offerts. Le conseil le plus fréquent selon les répondants était d’éviter la consommation d’alcool lorsqu’on prend des médicaments. De graves réactions indésirables, telles que la deterioration d’un trouble psychiatrique, l’admission à l’hôpital et une somnolence accrue, ont été soulignées par 23 participants. Soixante-neuf participants considéraient les médecins comme les meilleures sources d’information à propos de ces interactions.</p><strong>Conclusions : </strong>La plupart des participants ont indiqué avoir reçu de l’information sur les stratégies permettant d’éviter les conséquences des interactions alcool-médicaments. Certains ont tout de même consommé de l’alcool et près du quart des participants ont signalé une reaction indésirable grave liée à la consommation d’alcool. Ces données autodéclarées révèlent que les patients ne suivent pas nécessairement les conseils de leurs fournisseurs de soins de santé. Des études ultérieures devraient se pencher sur les raisons expliquant l’écart entre les conseils et les actions et sur les solutions pour réduire cet écart.


1975 ◽  
Vol 9 (11) ◽  
pp. 586-590 ◽  
Author(s):  
Curtis D. Black ◽  
Nicholas G. Popovich

At present, the pharmacist is faced with a perplexing number of potential drug interactions as they relate to patient care. The purpose of the investigation was to evaluate current drug-drug interaction literature, specifically gastrointestinal drug interactions. Literature search and review evaluated the authoritative basis on which conclusions were made. From this, a review was written to illustrate fallacies and misconceptions that could be derived from the literature with the intent it would serve as a guide in interpreting and evaluating drug-drug interactions. The overall study illustrates the vast need for careful evaluation of drug interaction literature before erroneous recommendations are made on conceivably inconclusive clinical studies.


2012 ◽  
Vol 15 (10) ◽  
pp. 1130-1136 ◽  
Author(s):  
Pedro Perez-Cruz ◽  
Linh Nguyen ◽  
Wadih Rhondali ◽  
David Hui ◽  
J. Lynn Palmer ◽  
...  

2017 ◽  
Vol 24 (03) ◽  
pp. 357-365
Author(s):  
Hina Hasnain ◽  
Huma Ali ◽  
Farya Zafar ◽  
Ali Akbar Sial ◽  
Kamran Hameed ◽  
...  

Drug-drug interaction (DDI) is a specific type of adverse event, which developsdue to multiple regimen therapy, and that may lead to significant hospitalization and death.Clinical and economic impact of drug interactions are increasingly accredited as a chiefconcern in critical care. Potentiating effects of DDIs in intensive care units are far more criticaldue to complex medications regimen, high risk severely ill population and associated metabolicand physiological disturbances which can impede drug effects. Pharmacist contribution isclassified as clarification of drug order, appropriate drug information provision, and advice forsubstitute treatment. A multidisciplinary approach is very necessary in developing a pharmacotherapeuticregimen designed to optimize patient outcome and minimize any potential dugdrug interactions. This review encompasses the prevalence, categorization, significance interm of patient safety and prescription efficacy, clinical and economic burdens, national andinternational data comparisons related to drug-drug interactions.


2013 ◽  
Vol 15 (5) ◽  
pp. e94 ◽  
Author(s):  
Erik Black ◽  
Jennifer Light ◽  
Nicole Paradise Black ◽  
Lindsay Thompson

2021 ◽  
Vol 12 (1) ◽  
pp. 248-253
Author(s):  
Bothiraj M ◽  
Alagusundaram M ◽  
Chandra Sekhar K B

Pharmacoepidemiology deals with the use and effects of medications in a large number of population—the combination of epidemiology principles to the effects of drug and its usage. Pharmacoepidemiology helps in optimal utilization of medicines and assist health care providers in making better decisions on drug therapy that will tend to curtail the Drug-Drug interactions, thereby prevents alteration in the pharmacological activity of one drug by another. Among all types of interaction, Drug-Drug interaction causes a higher rate of mortality. A prospective study conducted with 653 prescriptions that were collected from the various regions of Andhra Pradesh like Kadapa, Proddatur, Pulivendula, Kurnool are checked in interaction checker, results are projected in 4 categories a) Age and Sex preponderance(Demographics) rate of drugs interaction b) Interaction rate of major/minor type c) Department wise - General medicine (72.37%), Gynaec (69.02%), Pediatric (29.33%), Ophthalmology (75%) d) Most common interacting pairs of various department Ex: Ceftriaxone & Furosemide, Diclofenac & Furosemide, Albuterol & Losartan are observed in General Medicine. Statistical significance (P-value 0.00002) is obtained based on One Way ANOVA. This study elucidates the significance of pharmacoepidemiology; however, this requires much efforts to prevent causation effects of drugs. It is helpful to locate them by the establishment of “Drug interaction monitoring program” or by establishing “Pharmacoepidemiological centres” in every hospital for the screening of prescriptions by “Pharmacist” and thereby edify doctors and public for better medication use.


Sign in / Sign up

Export Citation Format

Share Document